Organogenesis Holdings Q4 Earnings Report: What Investors Need to Know

-1.81% Post

Organogenesis Holdings, Inc. Class A

ORGO

2.71

2.75

-1.81%

+1.48% Post

Organogenesis Holdings (NASDAQ:ORGO) reported its Q4 earnings results on Thursday, February 26, 2026 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Organogenesis Holdings beat estimated earnings by 90.48%, reporting an EPS of $0.4 versus an estimate of $0.21.

Revenue was up $98.95 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 44.73% increase in the share price the next day.

Here's a look at Organogenesis Holdings's past performance:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	0.070	-0.01	-0.030	0.02
EPS Actual	0.177	-0.06	-0.106	0.07
Revenue Estimate	134.10M	104.75M	90.77M	109.60M
Revenue Actual	150.86M	100.78M	86.70M	126.66M

To track all earnings releases for Organogenesis Holdings visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.